GDERF
Galderma Group AG operates as a dermatology company worldwide. The company delivers a science-based portfolio of brands and services for the dermatology market, including injectable aesthetics, dermatological skincare, and therapeutic dermatology. Its portfolio of flagship brands includes ACTINICA, Azzalure, ALLUZIENCE, Dysport, Restylane, Restylane Skinboosters, Sculptra, Cetaphil, ALASTIN, Sool… Read more
GDERF (GDERF) - Total Liabilities
Latest total liabilities as of June 2025: $5.15 Billion USD
Based on the latest financial reports, GDERF (GDERF) has total liabilities worth $5.15 Billion USD as of June 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
GDERF - Total Liabilities Trend (2023–2024)
This chart illustrates how GDERF's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
GDERF Competitors by Total Liabilities
The table below lists competitors of GDERF ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Public Bank Bhd
KLSE:1295
|
Malaysia | RM495.14 Billion |
|
Singapore Airlines Ltd
PINK:SINGY
|
USA | $24.72 Billion |
|
Kratos Defense & Security Solutions Inc.
LSE:0JS0
|
UK | $441.80 Million |
|
W P Carey Inc
NYSE:WPC
|
USA | $9.86 Billion |
|
Reliance Steel & Aluminum Co
NYSE:RS
|
USA | $3.19 Billion |
|
Entegris Inc
NASDAQ:ENTG
|
USA | $4.51 Billion |
|
Rentokil Initial PLC
NYSE:RTO
|
USA | $8.97 Billion |
|
Arm Holdings plc
F:O9T
|
Germany | €2.08 Billion |
Liability Composition Analysis (2023–2024)
This chart breaks down GDERF's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.09 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.67 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.40 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how GDERF's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for GDERF (2023–2024)
The table below shows the annual total liabilities of GDERF from 2023 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | $4.83 Billion | -32.03% |
| 2023-12-31 | $7.10 Billion | -- |